Stay updated on Ublituximab in RMS: Clinical Trial
Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.

Latest updates to the Ublituximab in RMS: Clinical Trial page
- Check6 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe revision label in the footer changes from v3.7.0 to v3.7.1; the study details remain inaccessible on the error page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study content and navigation with an access-restricted screen. This indicates the record is currently inaccessible.SummaryDifference18%

- Check55 days agoChange DetectedTwo metadata updates were made: a funding attribution line '2017 ( U.S. NIH Grant/Contract )' was added to the study identifiers, and the site revision string updated from v3.6.5 to v3.6.6. These changes reflect administrative information and versioning rather than substantive content changes to the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedAn error HTML page replaces the study record content, with a message that the page is currently unavailable. The study details and related materials are now inaccessible until the issue is resolved.SummaryDifference17%

- Check91 days agoChange DetectedFooter revision tag updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.0%

Stay in the know with updates to Ublituximab in RMS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.